MA39304A1 - Formulations topiques d'héparine - Google Patents
Formulations topiques d'héparineInfo
- Publication number
- MA39304A1 MA39304A1 MA39304A MA39304A MA39304A1 MA 39304 A1 MA39304 A1 MA 39304A1 MA 39304 A MA39304 A MA 39304A MA 39304 A MA39304 A MA 39304A MA 39304 A1 MA39304 A1 MA 39304A1
- Authority
- MA
- Morocco
- Prior art keywords
- heparin
- topical formulations
- present
- relates
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention se rapporte à des formulations topiques avancées de sels pharmaceutiquement acceptables d'héparine fournissant une meilleure pénétration transdermique. La présente invention concerne des formulations transparentes, non collantes liquides dans lesquelles le médicament est prêt pour l'absorption et qui sont appropriées pour l'administration sous la forme d'une solution ou d'une pulvérisation. Les formulations topiques de la présente invention ne forment pas de film de type feuilleté ou en gel sur la surface de la peau lors d'une application topique.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN475MU2014 | 2014-02-10 | ||
PCT/IB2015/050986 WO2015118512A1 (fr) | 2014-02-10 | 2015-02-10 | Formulations topiques d'héparine |
Publications (2)
Publication Number | Publication Date |
---|---|
MA39304A1 true MA39304A1 (fr) | 2018-01-31 |
MA39304B1 MA39304B1 (fr) | 2018-12-31 |
Family
ID=52684592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA39304A MA39304B1 (fr) | 2014-02-10 | 2015-02-10 | Formulations topiques d'héparine |
Country Status (25)
Country | Link |
---|---|
US (1) | US9861655B2 (fr) |
EP (1) | EP3104839B1 (fr) |
JP (1) | JP6275877B2 (fr) |
KR (1) | KR101822133B1 (fr) |
CN (1) | CN106163498A (fr) |
AP (1) | AP2016009350A0 (fr) |
AR (1) | AR099333A1 (fr) |
AU (1) | AU2015213569B2 (fr) |
CA (1) | CA2938388C (fr) |
CL (1) | CL2016001952A1 (fr) |
CU (1) | CU24444B1 (fr) |
DK (1) | DK3104839T3 (fr) |
DO (1) | DOP2016000198A (fr) |
EA (1) | EA032200B1 (fr) |
EC (1) | ECSP16069947A (fr) |
IL (1) | IL246974B (fr) |
MA (1) | MA39304B1 (fr) |
MX (1) | MX357765B (fr) |
MY (1) | MY182620A (fr) |
NZ (1) | NZ722830A (fr) |
PE (1) | PE20161173A1 (fr) |
PH (1) | PH12016501500B1 (fr) |
TW (1) | TWI538697B (fr) |
UA (1) | UA118279C2 (fr) |
WO (1) | WO2015118512A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011130455A1 (fr) * | 2010-04-13 | 2011-10-20 | Najib Babul | Compositions pharmaceutiques dermiques de 1-méthyl-2',6'-pipécoloxylidide et méthode d'utilisation |
CN112546061B (zh) * | 2021-02-25 | 2021-06-11 | 中南大学湘雅医院 | 一种肝素类药物组合物、喷鼻剂及其制备方法及应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3323389A1 (de) * | 1983-06-29 | 1985-01-10 | B. Braun Melsungen Ag, 3508 Melsungen | Auf schleimhaeute des mundes, der nase und/oder des rachens wirkende arzneimittel auf der basis von heparin und tensiden |
JPH02207018A (ja) * | 1989-02-07 | 1990-08-16 | Kao Corp | 皮膚外用剤 |
DE19536244A1 (de) | 1994-09-30 | 1996-04-04 | Juergen Dr Regenold | Pharmazeutische Zusammensetzung zur lokalen Applikation |
IT1275955B1 (it) | 1995-03-22 | 1997-10-24 | Dompe Spa | Formulazioni farmaceutiche in forma di gel tissotropico |
JPH10279466A (ja) * | 1997-04-07 | 1998-10-20 | Kose Corp | 外用剤 |
US6761903B2 (en) * | 1999-06-30 | 2004-07-13 | Lipocine, Inc. | Clear oil-containing pharmaceutical compositions containing a therapeutic agent |
BRPI0101486B1 (pt) | 2001-04-17 | 2017-09-19 | Cristália Produtos Químicos Farmacêuticos Ltda. | Pharmaceutical composition for topic use containing heparin for the treatment of skin or mucosal injuries caused by burns |
CN101583369B (zh) * | 2006-11-15 | 2015-03-11 | 关节炎缓痛补充剂有限公司 | 局部制剂及其用途 |
IT1400232B1 (it) * | 2010-05-07 | 2013-05-24 | Advance Holdings Ltd | Composizione farmaceutica topica comprendente eparina |
RU2013147883A (ru) * | 2011-04-01 | 2015-05-10 | Юниверсити Оф Флорида Рисеч Фаундэйшн, Инк. | Термочувствительные, мукоадгезивные или кожно-адгезивные и усиливающие проникновение композиции для местной доставки терапевтических средств |
-
2015
- 2015-02-10 NZ NZ722830A patent/NZ722830A/en unknown
- 2015-02-10 AP AP2016009350A patent/AP2016009350A0/en unknown
- 2015-02-10 JP JP2016568157A patent/JP6275877B2/ja active Active
- 2015-02-10 MY MYPI2016702732A patent/MY182620A/en unknown
- 2015-02-10 MA MA39304A patent/MA39304B1/fr unknown
- 2015-02-10 MX MX2016010399A patent/MX357765B/es active IP Right Grant
- 2015-02-10 DK DK15710252.6T patent/DK3104839T3/da active
- 2015-02-10 PE PE2016001445A patent/PE20161173A1/es unknown
- 2015-02-10 CA CA2938388A patent/CA2938388C/fr active Active
- 2015-02-10 CU CU2016000119A patent/CU24444B1/es unknown
- 2015-02-10 CN CN201580007796.6A patent/CN106163498A/zh active Pending
- 2015-02-10 AR ARP150100384A patent/AR099333A1/es unknown
- 2015-02-10 EA EA201691596A patent/EA032200B1/ru unknown
- 2015-02-10 WO PCT/IB2015/050986 patent/WO2015118512A1/fr active Application Filing
- 2015-02-10 UA UAA201608842A patent/UA118279C2/uk unknown
- 2015-02-10 AU AU2015213569A patent/AU2015213569B2/en not_active Ceased
- 2015-02-10 EP EP15710252.6A patent/EP3104839B1/fr active Active
- 2015-02-10 KR KR1020167023895A patent/KR101822133B1/ko active IP Right Grant
- 2015-02-10 US US15/116,060 patent/US9861655B2/en not_active Expired - Fee Related
- 2015-02-10 TW TW104104460A patent/TWI538697B/zh not_active IP Right Cessation
-
2016
- 2016-07-27 IL IL246974A patent/IL246974B/en active IP Right Grant
- 2016-07-28 PH PH12016501500A patent/PH12016501500B1/en unknown
- 2016-08-02 CL CL2016001952A patent/CL2016001952A1/es unknown
- 2016-08-03 DO DO2016000198A patent/DOP2016000198A/es unknown
- 2016-08-26 EC ECIEPI201669947A patent/ECSP16069947A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020500066A1 (en) | Carboxamides as modulators of sodium channels | |
MA38399A1 (fr) | Formulation sous forme de comprimé, utile pour traiter l'insuffisance cardiaque aiguë et l'insuffisance cardiaque chronique | |
CU20180125A7 (es) | Formulaciones líquidas de (s)-n-(5-((r)-2-(2,5-difluorofenil) -pirrolidin-1-il)-pirazolo[1,5-alpirimidin-3-il)-3 hidroxipirrolidina-1-carboxamida | |
IL260462B1 (en) | Gel preparations for administering a drug through the skin to maximize drug concentrations in the rough layer and serum and methods of using them | |
BRPI0707612B8 (pt) | vaso lacrado e formulações líquidas contidas no mesmo | |
EA201200096A1 (ru) | Фармацевтическая композиция ингибитора протеазы вируса гепатита c | |
EA200901112A1 (ru) | Жидкие композиции, образующие дермальные пленки, для введения лекарственных препаратов в кожу | |
MA39447B1 (fr) | Pirlindole ou ses sels pharmaceutiquement acceptables pour une utilisation en médecine | |
MA39304B1 (fr) | Formulations topiques d'héparine | |
CL2018002539A1 (es) | Ácido (2s,4r)-5-(5'-cloro-2'-fluoro-[1,1'-bifenil]-4-il)-2-(etoximetil)-4-(3-hidroxiisoxazol-5-carboxamido)-2-metilpentanoico cristalino, y sus usos | |
IL285073A (en) | Concentrated liquid pharmaceutical preparations of furosemide and methods of administering these preparations | |
MA39448A1 (fr) | (r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical | |
ZA202006986B (en) | Dantrolene formulations and methods of their use | |
EA201491652A1 (ru) | Средство для лечения вирусного гепатита с | |
EA202090298A1 (ru) | Способы лечения муковисцидоза | |
MD3987B1 (en) | Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency | |
AR107027A1 (es) | Moduladores de actividad complementaria | |
TH167851A (th) | (s)-เพอร์ลินโดล และเกลือที่ยอมรับได้ทางเภสัชกรรมของมันสำหรับ การใช้ในยารักษาโรค | |
WO2016115442A3 (fr) | Formulations de protéines thérapeutiques | |
PE20160748A1 (es) | Formacion de costra artificial porosa semipermeable | |
TH169402B (th) | สูตรตำรับเฉพาะที่ของเฮพาริน |